We create breath-based diagnostic and monitoring devices with the aim to improve the lives of those with respiratory conditions like asthma, COPD, cystic fibrosis and pulmonary hypertension.


Our Company

Spirosure is a medical device company based in Pleasanton, California focusing on research, development and commercialization of novel breath analysis devices for application in disease diagnosis and management.

Read More

Breath Analyzers

Fractional exhaled Nitric Oxide (FeNO) is a biomarker that indicates airway inflammation, a common side effect of patients with asthma and other pulmonary conditions. The Spirosure Fenom™ PRO point-of-care breath analyzer measures FeNO and is currently under investigational review.

Read More >

Connected Care

Our digital respiratory health solutions turn biometric and real world data into information that is meaningful and actionable, enabling patients to self manage and clinicians to make decisions more efficiently.

Read More >